Akinsanya Karen - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Akinsanya Karen
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-09-17
Sale
2026-09-21
5:15 pm
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
31,599$29.37$927,97081,555
(Direct)
View
2026-03-05
Sale
2026-03-06
5:27 pm
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
1,366$12.9$17,62569,956
(Direct)
View
2026-03-02
Sale
2026-03-03
4:31 pm
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
2,206$11.99$26,454119,822
(Direct)
View
2025-04-14
Sale
2025-04-15
4:31 pm
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
16,723$25.09$419,57015,625
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2026-09-17
Exercise
2026-09-21
5:15 pm
N/A
2028-11-29
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
31,599$081,555
(Direct)
View
2026-09-17
Exercise
2026-09-21
5:15 pm
N/A
N/A
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
31,599$4.3481,555
(Direct)
View
2026-06-18
Option Award
2026-06-22
4:13 pm
N/A
2036-06-18
Nautilus Biotechnology Inc.NAUTAkinsanya Karen
Director
45,000$045,000
(Direct)
View
2026-03-02
Option Award
2026-03-03
4:31 pm
N/A
2036-03-02
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
106,403$0119,822
(Direct)
View
2025-06-23
Option Award
2025-06-25
4:36 pm
N/A
2035-06-23
Nautilus Biotechnology Inc.NAUTAkinsanya Karen
Director
45,000$045,000
(Direct)
View
2025-04-14
Exercise
2025-04-15
4:31 pm
N/A
2028-08-03
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
16,723$015,625
(Direct)
View
2025-04-14
Exercise
2025-04-15
4:31 pm
N/A
N/A
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
13,378$3.2215,625
(Direct)
View
2025-04-14
Exercise
2025-04-15
4:31 pm
N/A
N/A
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
3,345$2.9215,625
(Direct)
View
2025-03-03
Option Award
2025-03-04
5:29 pm
N/A
2035-03-03
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
78,125$078,125
(Direct)
View
2024-06-14
Option Award
2024-06-17
5:40 pm
N/A
2034-06-14
Nautilus Biotechnology Inc.NAUTAkinsanya Karen
Director
45,000$045,000
(Direct)
View
2024-03-04
Option Award
2024-03-05
4:44 pm
N/A
2034-03-04
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
120,000$0120,000
(Direct)
View
2023-06-15
Option Award
2023-06-16
7:51 pm
N/A
2033-06-15
Nautilus Biotechnology Inc.NAUTAkinsanya Karen
Director
45,000$045,000
(Direct)
View
2023-02-09
Option Award
2023-02-10
4:59 pm
N/A
2033-02-09
Schrodinger Inc.SDGRAkinsanya Karen
President of R&D, Therapeutics
63,270$063,270
(Direct)
View
2022-06-15
Option Award
2022-06-16
8:03 pm
N/A
2032-06-15
Nautilus Biotechnology Inc.NAUTAkinsanya Karen
Director
14,411$014,411
(Direct)
View
2022-03-30
Option Award
2022-03-31
6:16 pm
N/A
2032-03-30
Nautilus Biotechnology Inc.NAUTAkinsanya Karen
Director
105,998$0105,998
(Direct)
View
2022-02-09
Option Award
2022-02-09
9:14 pm
N/A
2032-02-09
Schrodinger Inc.SDGRAkinsanya Karen
See Remarks
80,000$080,000
(Direct)
View